| 1 |
Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory Bowel Diseases and Gut Microbiota. Int J Mol Sci 2023;24. [PMID: 36835245 DOI: 10.3390/ijms24043817] [Reference Citation Analysis]
|
| 2 |
Qu D, Feng S, Li M, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Effects of Bifidobacteria bifidum strains on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced acute colitis and its potential mechanism. Food Bioscience 2023. [DOI: 10.1016/j.fbio.2023.102387] [Reference Citation Analysis]
|
| 3 |
Wei L, Duan L, Zhao H, Tai J. Role of a mixed probiotic product, VSL#3, in the prevention and treatment of colorectal cancer. Eur J Pharmacol 2022;:175152. [PMID: 35835181 DOI: 10.1016/j.ejphar.2022.175152] [Reference Citation Analysis]
|
| 4 |
Wang X, Zhao J, Feng Y, Feng Z, Ye Y, Liu L, Kang G, Cao X. Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:916543. [DOI: 10.3389/fcimb.2022.916543] [Reference Citation Analysis]
|
| 5 |
Fong FLY, El-Nezami H, Mykkänen O, Kirjavainen PV. The Effects of Single Strains and Mixtures of Probiotic Bacteria on Immune Profile in Liver, Spleen, and Peripheral Blood. Front Nutr 2022;9:773298. [PMID: 35495948 DOI: 10.3389/fnut.2022.773298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Odekina GO, Adedotun AF, Imaga OF. Modeling and Forecasting the Third wave of Covid-19 Incidence Rate in Nigeria Using Vector Autoregressive Model Approach. J Nig Soc Phys Sci 2022. [DOI: 10.46481/jnsps.2022.431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Su L, Hong Z, Zhou T, Jian Y, Xu M, Zhang X, Zhu X, Wang J. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. Sci Rep 2022;12:1152. [PMID: 35064189 DOI: 10.1038/s41598-022-05127-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Feng S, Li J, Qu D, Tian F, Yu L, Zhang H, Chen W, Zhao J, Zhai Q. Characteristics of an In Vitro Mesenteric Lymph Node Cell Suspension Model and Its Possible Association with In Vivo Functional Evaluation. Int J Mol Sci 2022;23:1003. [PMID: 35055188 DOI: 10.3390/ijms23021003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Cruz BCDS, de Sousa Moraes LF, De Nadai Marcon L, Dias KA, Murad LB, Sarandy MM, Conceição LLD, Gonçalves RV, Ferreira CLLF, Peluzio MDCG. Evaluation of the efficacy of probiotic VSL#3 and synbiotic VSL#3 and yacon-based product in reducing oxidative stress and intestinal permeability in mice induced to colorectal carcinogenesis. J Food Sci 2021;86:1448-62. [PMID: 33761141 DOI: 10.1111/1750-3841.15690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother 2021;133:110947. [PMID: 33197765 DOI: 10.1016/j.biopha.2020.110947] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 11 |
Sokolova M, Yang K, Hansen SH, Louwe MC, Kummen M, Hov JER, Sjaastad I, Berge RK, Halvorsen B, Aukrust P, Yndestad A, Ranheim T. NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet. Sci Rep 2020;10:21006. [PMID: 33273482 DOI: 10.1038/s41598-020-76497-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 12 |
Bernardazzi C, Xu H, Tong H, Laubitz D, Figliuolo da Paz V, Curiel L, Ghishan FK. An indisputable role of NHE8 in mucosal protection. Am J Physiol Gastrointest Liver Physiol 2020;319:G421-31. [PMID: 32755385 DOI: 10.1152/ajpgi.00246.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 13 |
dos Santos Cruz BC, da Silva Duarte V, Giacomini A, Corich V, de Paula SO, da Silva Fialho L, Guimarães VM, de Luces Fortes Ferreira CL, Gouveia Peluzio MDC. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model. Appl Microbiol Biotechnol 2020;104:8837-57. [DOI: 10.1007/s00253-020-10863-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Kaur H, Nagamoto-Combs K, Golovko S, Golovko MY, Klug MG, Combs CK. Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer's disease. Neurobiol Aging 2020;92:114-34. [PMID: 32417748 DOI: 10.1016/j.neurobiolaging.2020.04.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 15 |
Wilson KM, Rodrigues DR, Briggs WN, Duff AF, Chasser KM, Bielke LR. Evaluation of the impact of in ovo administered bacteria on microbiome of chicks through 10 days of age. Poult Sci 2019;98:5949-60. [PMID: 31298298 DOI: 10.3382/ps/pez388] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 16 |
Hoffman JD, Yanckello LM, Chlipala G, Hammond TC, McCulloch SD, Parikh I, Sun S, Morganti JM, Green SJ, Lin AL. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model. PLoS One 2019;14:e0221828. [PMID: 31461505 DOI: 10.1371/journal.pone.0221828] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 17 |
Yu L, Qiao N, Li T, Yu R, Zhai Q, Tian F, Zhao J, Zhang H, Chen W. Dietary supplementation with probiotics regulates gut microbiota structure and function in Nile tilapia exposed to aluminum. PeerJ 2019;7:e6963. [PMID: 31198632 DOI: 10.7717/peerj.6963] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 18 |
Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med 2019;25:716-29. [DOI: 10.1038/s41591-019-0439-x] [Cited by in Crossref: 405] [Cited by in F6Publishing: 421] [Article Influence: 101.3] [Reference Citation Analysis]
|
| 19 |
Grill A, Reinhardt C. Germ-Free Mouse Technology in Cardiovascular Research. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications 2019. [DOI: 10.1016/b978-0-12-815249-2.00002-6] [Reference Citation Analysis]
|
| 20 |
Shi C, Li H, Qu X, Huang L, Kong C, Qin H, Sun Z, Yan X. High fat diet exacerbates intestinal barrier dysfunction and changes gut microbiota in intestinal-specific ACF7 knockout mice. Biomed Pharmacother 2019;110:537-45. [PMID: 30530289 DOI: 10.1016/j.biopha.2018.11.100] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 21 |
Saniabadi AR, Tanaka T, Yamamoto T, Kruis W, Sacco R. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes. J Clin Apher. 2019;34:51-60. [PMID: 30407662 DOI: 10.1002/jca.21670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 22 |
Angelakis E, Bachar D, Yasir M, Musso D, Djossou F, Gaborit B, Brah S, Diallo A, Ndombe GM, Mediannikov O, Robert C, Azhar EI, Bibi F, Nsana NS, Parra HJ, Akiana J, Sokhna C, Davoust B, Dutour A, Raoult D. Treponema species enrich the gut microbiota of traditional rural populations but are absent from urban individuals. New Microbes New Infect 2019;27:14-21. [PMID: 30555706 DOI: 10.1016/j.nmni.2018.10.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 23 |
Carvalho R, Vaz A, Pereira FL, Dorella F, Aguiar E, Chatel JM, Bermudez L, Langella P, Fernandes G, Figueiredo H, Goes-Neto A, Azevedo V. Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. Sci Rep 2018;8:15072. [PMID: 30305667 DOI: 10.1038/s41598-018-33469-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 24 |
Shamriz O. Probiotics and autoimmunity: Current evidence. Autoimmun Rev 2018;17:1150-1. [PMID: 30213698 DOI: 10.1016/j.autrev.2018.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 25 |
Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int 2018;120:149-63. [PMID: 30114473 DOI: 10.1016/j.neuint.2018.08.005] [Cited by in Crossref: 132] [Cited by in F6Publishing: 111] [Article Influence: 26.4] [Reference Citation Analysis]
|
| 26 |
Wang Y, Gu Y, Fang K, Mao K, Dou J, Fan H, Zhou C, Wang H. Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors. Benef Microbes. 2018;9:775-787. [PMID: 30014710 DOI: 10.3920/bm2017.0035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 27 |
Kling DN, Teixeira LD, Debose-scarlett EM, Gonzalez CF. A Network of Physiological Interactions Modulating GI Homeostasis: Probiotics, Inflammasome, mTOR. Probiotics - Current Knowledge and Future Prospects 2018. [DOI: 10.5772/intechopen.72656] [Reference Citation Analysis]
|
| 28 |
Sun X, Winglee K, Gharaibeh RZ, Gauthier J, He Z, Tripathi P, Avram D, Bruner S, Fodor A, Jobin C. Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice. Gastroenterology 2018;154:1751-1763.e2. [PMID: 29408609 DOI: 10.1053/j.gastro.2018.01.042] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 29 |
Wang J, Tang L, Zhou H, Zhou J, Glenn TC, Shen CL, Wang JS. Long-term treatment with green tea polyphenols modifies the gut microbiome of female sprague-dawley rats. J Nutr Biochem. 2018;56:55-64. [PMID: 29454999 DOI: 10.1016/j.jnutbio.2018.01.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 30 |
Osaka T, Moriyama E, Arai S, Date Y, Yagi J, Kikuchi J, Tsuneda S. Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases. Nutrients 2017;9:E1329. [PMID: 29211010 DOI: 10.3390/nu9121329] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 31 |
Isidro RA, Lopez A, Cruz ML, Gonzalez Torres MI, Chompre G, Isidro AA, Appleyard CB. The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis. J Histochem Cytochem. 2017;65:445-461. [PMID: 28692320 DOI: 10.1369/0022155417718542] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 32 |
White R, Atherly T, Guard B, Rossi G, Wang C, Mosher C, Webb C, Hill S, Ackermann M, Sciabarra P, Allenspach K, Suchodolski J, Jergens AE. Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease. Gut Microbes 2017;8:451-66. [PMID: 28678609 DOI: 10.1080/19490976.2017.1334754] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 33 |
Cinque B, La Torre C, Lombardi F, Palumbo P, Evtoski Z, Jr Santini S, Falone S, Cimini A, Amicarelli F, Cifone MG. VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function. J Cell Physiol 2017;232:3530-9. [PMID: 28109129 DOI: 10.1002/jcp.25814] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 34 |
Celiberto LS, Bedani R, Dejani NN, Ivo de Medeiros A, Sampaio Zuanon JA, Spolidorio LC, Tallarico Adorno MA, Amâncio Varesche MB, Carrilho Galvão F, Valentini SR, Font de Valdez G, Rossi EA, Cavallini DCU. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. PLoS One 2017;12:e0175935. [PMID: 28437455 DOI: 10.1371/journal.pone.0175935] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 35 |
Celiberto LS, Bedani R, Rossi EA, Cavallini DC. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr 2017;57:1759-68. [PMID: 25996176 DOI: 10.1080/10408398.2014.941457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Schrumpf E, Kummen M, Valestrand L, Greiner TU, Holm K, Arulampalam V, Reims HM, Baines J, Bäckhed F, Karlsen TH, Blumberg RS, Hov JR, Melum E. The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation. J Hepatol 2017;66:382-9. [PMID: 27720803 DOI: 10.1016/j.jhep.2016.09.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 37 |
Qiao YQ, Cai CW, Ran ZH. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. J Dig Dis 2016;17:800-10. [PMID: 27743467 DOI: 10.1111/1751-2980.12422] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 38 |
Chung EJ, Do EJ, Kim SY, Cho EA, Kim DH, Pak S, Hwang SW, Lee HJ, Byeon JS, Ye BD, Yang DH, Park SH, Yang SK, Kim JH, Myung SJ. Combination of metformin and VSL#3 additively suppresses western-style diet induced colon cancer in mice. Eur J Pharmacol. 2017;794:1-7. [PMID: 27845068 DOI: 10.1016/j.ejphar.2016.11.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 39 |
Vázquez-baeza Y, Hyde ER, Suchodolski JS, Knight R. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks. Nat Microbiol 2016;1. [DOI: 10.1038/nmicrobiol.2016.177] [Cited by in Crossref: 120] [Cited by in F6Publishing: 124] [Article Influence: 17.1] [Reference Citation Analysis]
|
| 40 |
Stefanis C, Mantzourani I, Plessas S, Alexopoulos A, Galanis A, Bezirtzoglou E, Kandylis P, Varzakas T. Reviewing Classical and Molecular Techniques Regarding Profiling of Probiotic Character of Microorganisms. Curr Res Nutr Food Sci 2016;4:27-47. [DOI: 10.12944/crnfsj.4.1.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 41 |
Shi H, Sun H, Zheng R, Lu S, Liu F, Zhang N, Xue C, Tang Q. The Modulatory Effect of Dietary <i>Apostichopus japonicus</i> on Mice with Ulcerative Colitis Induced by Trinitrobenzene Sulfonic Acid. JBM 2016;04:15-27. [DOI: 10.4236/jbm.2016.410003] [Reference Citation Analysis]
|
| 42 |
Larmonier CB, Shehab KW, Ghishan FK, Kiela PR. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome. Biomed Res Int. 2015;2015:504638. [PMID: 26583115 DOI: 10.1155/2015/504638] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 43 |
Talero E, Bolivar S, Ávila-Román J, Alcaide A, Fiorucci S, Motilva V. Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3. Inflamm Bowel Dis 2015;21:1027-37. [PMID: 25793324 DOI: 10.1097/MIB.0000000000000346] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 44 |
Souza DG, Senchenkova EY, Russell J, Granger DN. MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis. Inflamm Bowel Dis 2015;21:888-900. [PMID: 25738377 DOI: 10.1097/MIB.0000000000000331] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 45 |
Eaton K, Yang W; Reproducibility Project: Cancer Biology. Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 2015;4. [PMID: 25781343 DOI: 10.7554/eLife.04186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 46 |
Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 47 |
Mar JS, Nagalingam NA, Song Y, Onizawa M, Lee JW, Lynch SV. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition. Gut Microbes 2014;5:494-503. [PMID: 25144681 DOI: 10.4161/gmic.32147] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 48 |
Kelder T, Stroeve JH, Bijlsma S, Radonjic M, Roeselers G. Correlation network analysis reveals relationships between diet-induced changes in human gut microbiota and metabolic health. Nutr Diabetes 2014;4:e122. [PMID: 24979151 DOI: 10.1038/nutd.2014.18] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 49 |
Shanahan MT, Carroll IM, Grossniklaus E, White A, von Furstenberg RJ, Barner R, Fodor AA, Henning SJ, Sartor RB, Gulati AS. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 2014;63:903-10. [PMID: 23512834 DOI: 10.1136/gutjnl-2012-304190] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 50 |
Rashid SK, Idris-Khodja N, Auger C, Alhosin M, Boehm N, Oswald-Mammosser M, Schini-Kerth VB. Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension: role of the angiotensin system. PLoS One. 2014;9:e97458. [PMID: 24832090 DOI: 10.1371/journal.pone.0097458] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 51 |
Fukuda K, Fujita Y. Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2014;14:49. [PMID: 24641276 DOI: 10.1186/1471-230x-14-49] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 52 |
Vieira AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol. 2013;4:445. [PMID: 24376446 DOI: 10.3389/fimmu.2013.00445] [Cited by in Crossref: 154] [Cited by in F6Publishing: 159] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 53 |
Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, Lencer WI, Jobin C, Blumberg RS. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 2013;39:1095-107. [PMID: 24290911 DOI: 10.1016/j.immuni.2013.11.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 54 |
Pagnini C, Fave GD, Bamias G. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World J Immunol 2013; 3(3): 31-43 [DOI: 10.5411/wji.v3.i3.31] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 55 |
Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep. 2013;3:2868. [PMID: 24100376 DOI: 10.1038/srep02868] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 56 |
Ahmed J, Reddy BS, Mølbak L, Leser TD, MacFie J. Impact of probiotics on colonic microflora in patients with colitis: a prospective double blind randomised crossover study. Int J Surg 2013;11:1131-6. [PMID: 24060951 DOI: 10.1016/j.ijsu.2013.08.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 57 |
Carvalho BM, Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm. 2013;2013:986734. [PMID: 23840101 DOI: 10.1155/2013/986734] [Cited by in Crossref: 72] [Cited by in F6Publishing: 85] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 58 |
Yoo S, Kim Y, Park D, Jung U, Jeon S, Ahn Y, Huh C, Mcgregor R, Choi MS. Probiotics L. plantarum and L. curvatus in Combination Alter Hepatic Lipid Metabolism and Suppress Diet-Induced Obesity: Novel Probiotic for Suppression of Obesity. Obesity 2013;21:2571-8. [DOI: 10.1002/oby.20428] [Cited by in Crossref: 141] [Cited by in F6Publishing: 144] [Article Influence: 14.1] [Reference Citation Analysis]
|
| 59 |
Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients. 2013;5:1869-1912. [PMID: 23760057 DOI: 10.3390/nu5061869] [Cited by in Crossref: 289] [Cited by in F6Publishing: 304] [Article Influence: 28.9] [Reference Citation Analysis]
|
| 60 |
Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO, van Sinderen D. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 2014;71:183-203. [PMID: 23516017 DOI: 10.1007/s00018-013-1318-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 175] [Article Influence: 19.9] [Reference Citation Analysis]
|
| 61 |
Sung MK, Park MY. Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view. World J Gastroenterol 2013; 19(7): 994-1004 [PMID: 23467687 DOI: 10.3748/wjg.v19.i7.994] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 62 |
Kim SW, Park KY, Kim B, Kim E, Hyun CK. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun. 2013;431:258-263. [PMID: 23313485 DOI: 10.1016/j.bbrc.2012.12.121] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 63 |
Kullisaar T, Türk S, Punab M, Veskioja A, Songisepp E, Zilmer K, Zilmer M. Dietary Modification of Lower Urinary Tract Symptoms with Fermented Whey Product. OJU 2013;03:114-120. [DOI: 10.4236/oju.2013.32022] [Reference Citation Analysis]
|
| 64 |
Reid G. Probiotics. The Prokaryotes 2013. [DOI: 10.1007/978-3-642-30144-5_89] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 65 |
Fedorak R, Demeria D. Probiotic bacteria in the prevention and the treatment of inflammatory bowel disease. Gastroenterol Clin North Am 2012;41:821-42. [PMID: 23101689 DOI: 10.1016/j.gtc.2012.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 66 |
Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229-244. [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6] [Cited by in Crossref: 343] [Cited by in F6Publishing: 368] [Article Influence: 31.2] [Reference Citation Analysis]
|
| 67 |
Nanau RM, Neuman MG. Nutritional and probiotic supplementation in colitis models. Dig Dis Sci 2012;57:2786-810. [PMID: 22736018 DOI: 10.1007/s10620-012-2284-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 68 |
Veerappan GR, Betteridge J, Young PE. Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep. 2012;14:324-333. [PMID: 22581276 DOI: 10.1007/s11894-012-0265-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 69 |
Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, Jiang M. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 2013;374:1-11. [PMID: 23271629 DOI: 10.1007/s11010-012-1488-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 70 |
Zhang HL, Yu LX, Yang W, Tang L, Lin Y, Wu H, Zhai B, Tan YX, Shan L, Liu Q, Chen HY, Dai RY, Qiu BJ, He YQ, Wang C, Zheng LY, Li YQ, Wu FQ, Li Z, Yan HX, Wang HY. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 2012;57:803-12. [PMID: 22727732 DOI: 10.1016/j.jhep.2012.06.011] [Cited by in Crossref: 180] [Cited by in F6Publishing: 190] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 71 |
Mariman R, Kremer B, van Erk M, Lagerweij T, Koning F, Nagelkerken L. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis 2012;18:1424-33. [PMID: 22162025 DOI: 10.1002/ibd.22849] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 72 |
Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs. 2012;72:803-823. [PMID: 22512365 DOI: 10.2165/11632710-000000000-00000] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 73 |
Zhang X, Choi FF, Zhou Y, Leung FP, Tan S, Lin S, Xu H, Jia W, Sung JJ, Cai Z, Bian Z. Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics--a pilot study. FEBS J 2012;279:2322-38. [PMID: 22520047 DOI: 10.1111/j.1742-4658.2012.08612.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 74 |
Kelly D, Delday MI, Mulder I. Microbes and microbial effector molecules in treatment of inflammatory disorders. Immunol Rev 2012;245:27-44. [PMID: 22168412 DOI: 10.1111/j.1600-065X.2011.01079.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 75 |
Macia L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev. 2012;245:164-176. [PMID: 22168419 DOI: 10.1111/j.1600-065X.2011.01080.x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 164] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 76 |
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One. 2012;7:e34676. [PMID: 22511958 DOI: 10.1371/journal.pone.0034676] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 77 |
Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One 2012;7:e31238. [PMID: 22363592 DOI: 10.1371/journal.pone.0031238] [Cited by in Crossref: 101] [Cited by in F6Publishing: 110] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 78 |
Lee JH, Moon G, Kwon HJ, Jung WJ, Seo PJ, Baec TY, Lee JH, Kim HS. Effect of a Probiotic Preparation (VSL#3) in Patients with Mild to Moderate Ulcerative Colitis. Korean J Gastroenterol 2012;60:94. [DOI: 10.4166/kjg.2012.60.2.94] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 79 |
Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol 2011;301:G1004-13. [PMID: 21903764 DOI: 10.1152/ajpgi.00167.2011] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 80 |
Tang Y, Forsyth CB, Keshavarzian A. New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol 2011;5:615-25. [PMID: 21910579 DOI: 10.1586/egh.11.64] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 81 |
Dave M, Johnson LA, Walk ST, Young VB, Stidham RW, Chaudhary MN, Funnell J, Higgins PD. A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum. Gut 2011;60:1043-9. [PMID: 21317176 DOI: 10.1136/gut.2010.224337] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 82 |
Oliveira M, Bosco N, Perruisseau G, Nicolas J, Segura-Roggero I, Duboux S, Briand M, Blum S, Benyacoub J. Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis. Clin Dev Immunol 2011;2011:807483. [PMID: 21808650 DOI: 10.1155/2011/807483] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 83 |
Day AS, Keenan JI. Probiotic-mediated modulation of host inflammation. Expert Rev Gastroenterol Hepatol 2011;5:319-21. [PMID: 21651350 DOI: 10.1586/egh.11.34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 84 |
Jobin C. Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer? Gut Microbes 2010;1:196-9. [PMID: 21327025 DOI: 10.4161/gmic.1.3.12485] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
